Connect
MJA
MJA

Technologies in the management of type 1 diabetes

Jennifer R Snaith and D Jane Holmes‐Walker
Med J Aust 2021; 214 (5): . || doi: 10.5694/mja2.50946
Published online: 1 March 2021

Technology is changing the way that people with type 1 diabetes are monitoring and managing their blood glucose levels

Diabetes technologies have transformed management options in type 1 diabetes. The most notable innovations include the commercialisation of insulin pumps, advancements in glucose monitoring and the capacity for these technologies to interact. New technologies offer enhanced flexibility in insulin delivery and opportunities to improve glucose levels and enhance quality of life. Recognising these benefits, the uptake of advanced technologies in Australians with type 1 diabetes has increased. In 2018–2019, 41% of children and 26% of adults attending hospital diabetes clinics managed their type 1 diabetes with insulin pumps, and 55% of children and 13% of adults newly commenced continuous glucose monitoring (CGM).1 In this article, we provide a guide to current diabetes technologies available in Australia, describe their benefits and discuss important factors in assessing an individual’s suitability.

  • Jennifer R Snaith1,2
  • D Jane Holmes‐Walker3,4

  • 1 Garvan Institute of Medical Research, Sydney, NSW
  • 2 St Vincent’s Hospital, Sydney, NSW
  • 3 Westmead Hospital, Westmead, NSW
  • 4 Westmead Medical School, University of Sydney, Sydney, NSW


Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.